Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1431)
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
4,861
Price
$145.43
Total Value
$706.96K
Shares Held After
16,295
% of Holdings
23.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
3,748
Price
$144.66
Total Value
$542.19K
Shares Held After
21,156
% of Holdings
15.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
96
Price
$143.90
Total Value
$13.81K
Shares Held After
24,904
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
1,000
Price
$52.50
Total Value
$52.50K
Shares Held After
135,215
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
1,000
Price
$52.50
Total Value
$52.50K
Shares Held After
135,215
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
22,236
Price
$52.50
Total Value
$1.17M
Shares Held After
474,703
% of Holdings
4.5%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
225
Price
$52.51
Total Value
$11.81K
Shares Held After
496,939
% of Holdings
0.0%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
10,000
Price
$53.00
Total Value
$530.00K
Shares Held After
104,395
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
400
Price
$551.74
Total Value
$220.70K
Shares Held After
45,172
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
496
Price
$548.91
Total Value
$272.26K
Shares Held After
45,572
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
881
Price
$547.65
Total Value
$482.48K
Shares Held After
46,068
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
157
Price
$546.15
Total Value
$85.74K
Shares Held After
46,949
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
480
Price
$544.26
Total Value
$261.25K
Shares Held After
47,106
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
160
Price
$541.95
Total Value
$86.71K
Shares Held After
47,586
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
950
Price
$541.25
Total Value
$514.19K
Shares Held After
47,746
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
798
Price
$540.25
Total Value
$431.12K
Shares Held After
48,696
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,305
Price
$539.42
Total Value
$703.94K
Shares Held After
49,494
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
958
Price
$538.03
Total Value
$515.43K
Shares Held After
50,799
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,715
Price
$537.04
Total Value
$921.03K
Shares Held After
51,757
% of Holdings
3.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,902
Price
$90.38
Total Value
$1.17M
Shares Held After
662,042
% of Holdings
1.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
92,169
Price
$90.38
Total Value
$8.33M
Shares Held After
3,807,660
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,741
Price
$89.98
Total Value
$1.06M
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
27,695
Price
$0.35
Total Value
$9.69K
Shares Held After
303,719
% of Holdings
8.4%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
389,216
Price
$0.35
Total Value
$136.23K
Shares Held After
4,268,448
% of Holdings
8.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
309
Price
$79.25
Total Value
$24.49K
Shares Held After
105,272
% of Holdings
0.3%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,703
Price
$78.50
Total Value
$133.69K
Shares Held After
105,581
% of Holdings
1.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,850
Price
$79.24
Total Value
$146.59K
Shares Held After
105,272
% of Holdings
1.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
6,600
Price
$78.50
Total Value
$518.10K
Shares Held After
107,122
% of Holdings
5.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,238
Price
$44.75
Total Value
$55.40K
Shares Held After
51,000
% of Holdings
2.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
3,401
Price
$43.86
Total Value
$149.18K
Shares Held After
52,238
% of Holdings
6.1%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,379
Price
$42.78
Total Value
$59.00K
Shares Held After
55,639
% of Holdings
2.4%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,133
Price
$44.74
Total Value
$50.69K
Shares Held After
25,000
% of Holdings
4.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,599
Price
$43.87
Total Value
$114.02K
Shares Held After
26,133
% of Holdings
9.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,268
Price
$42.83
Total Value
$54.30K
Shares Held After
28,732
% of Holdings
4.2%
PTC THERAPEUTICS, INC. (PTCT)
Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Shares
19,686
Price
$75.56
Total Value
$1.49M
Shares Held After
70,199
% of Holdings
21.9%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
5,418
Price
$61.81
Total Value
$334.89K
Shares Held After
847,991
% of Holdings
0.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
4,582
Price
$61.24
Total Value
$280.60K
Shares Held After
853,409
% of Holdings
0.5%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
25
Price
$112.23
Total Value
$2.81K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,887
Price
$111.31
Total Value
$210.05K
Shares Held After
25
% of Holdings
98.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
2,390
Price
$110.26
Total Value
$263.52K
Shares Held After
1,912
% of Holdings
55.6%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
37,454
Price
$20.14
Total Value
$754.32K
Shares Held After
4,159,119
% of Holdings
0.9%
Pasithea Therapeutics Corp. (KTTA)
Coastlands Capital LP — 10% Owner
Shares
100,000
Price
$0.53
Total Value
$53.00K
Shares Held After
3,835,035
% of Holdings
2.6%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
1,690
Price
$42.60
Total Value
$71.99K
Shares Held After
43,254
% of Holdings
3.8%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
4,700
Price
$43.66
Total Value
$205.20K
Shares Held After
44,944
% of Holdings
9.5%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
5,295
Price
$47.08
Total Value
$249.29K
Shares Held After
49,644
% of Holdings
9.6%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
5,295
Price
$42.57
Total Value
$225.41K
Shares Held After
25,996
% of Holdings
16.9%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
11,585
Price
$48.65
Total Value
$563.61K
Shares Held After
558,810
% of Holdings
2.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
33,334
Price
$45.01
Total Value
$1.50M
Shares Held After
570,395
% of Holdings
5.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
56,929
Price
$43.43
Total Value
$2.47M
Shares Held After
603,729
% of Holdings
8.6%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
32,581
Price
$45.02
Total Value
$1.47M
Shares Held After
660,658
% of Holdings
4.7%
Showing 651–700 of 1431 transactions (page 14 of 29)